Send to a Friend Font Size: Increase Decrease

OrbiMed Advisors

OrbiMed Advisors's Portfolio

Last Updated on 5/16/11 @ 11:13am

Ticker	# of Shares	Price	Value
	73,114,592	$1,141.93	$83,491,746,043
	22,362,850	$1,141.93	$25,536,809,301
	17,233,668	$1,141.93	$19,679,642,500
	14,567,176	$1,141.93	$16,634,695,290
	9,033,726	$1,141.93	$10,315,882,732
	8,998,338	$1,141.93	$10,275,472,113
	8,322,140	$1,141.93	$9,503,301,331
	8,009,729	$1,141.93	$9,146,549,837
	7,619,135	$1,141.93	$8,700,518,831
View Additional Portfolio Information »

http://www.orbimed.com/OrbiMed is the world's largest healthcare-dedicated investment firm, with approximately $5 billion in assets under management. The firm was stated in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies.

Login to help us fill in information about this entity.

9 Meters Biopharma Provides Business Update and Reports Financial Results for the Fourth Quarter and Full Year 2020 Mar 22, 2021 04:00PM

9 Meters Biopharma, Inc Announces the Closing of Naia Rare Diseases Acquisition May 7, 2020 07:00AM

9 Meters Biopharma, Inc Announces the Closing of $22.5 Million Private Placement Funding May 4, 2020 05:30PM

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)

Market Snapshot

Free News Feed